Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 2Choledocholithiasis 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Papillomavirus Infections 1Pancreatitis 1Pain 1Choledochal Cyst 1Cholangitis 1Cholangiocarcinoma 1Carcinoma in Situ 1Agnosia 1

Interventions

Midazolam 2Meperidine 2Ketamine 1Etomidate 1Duodenoscopes 1Blood Culture 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Choledocholithiasis × Meperidine × Clear all
NCT06111872 2025-03-25

Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.

National University of Malaysia

Phase 2 Completed
90 enrolled
Gastrointestinal

Cholangitis, Pancreatic Neoplasms, Choledochal Cyst, Choledocholithiasis

NCT02027311 2015-06-29

Etomidate vs. Midazolam for Sedation During ERCP

Cheju Halla General Hospital

Phase 4 Completed
63 enrolled 9 charts
Gastrointestinal

Pancreatic Neoplasms, Pancreatitis, Cholangiocarcinoma, Choledocholithiasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡